Literature DB >> 35342463

Personalized nuclear imaging protocol in cases with nodular goiter and parathyroid adenoma.

W Jalloul1,2, R Tibu1, T M Ionescu1, C R Stolniceanu1,2, I Grierosu1,2, A Tarca1, L Ionescu3,2, M C Ungureanu4,2, D Ciobanu5,2, V Ghizdovat2, C Stefanescu1,2.   

Abstract

A 62 years old woman was diagnosed with multinodular toxic goiter and primary hyperparathyroidism/left parathyroid adenoma by hormonal assessment, ultrasound and nuclear thyroid/parathyroid scans. Cervical ultrasound illustrated a multinodular aspect of the thyroid with solid nodules and cystic-component nodules; the larger one represented a multinodular complex with necrosis areas in the left thyroid lobe, ACR TI-RADS score 4 (moderately suspicious). Functional nuclear imaging was performed for accurate differential diagnosis between thyroid vs. parathyroid localization, between cold vs. hot nodules, and eventually, for guiding the choice of a subsequent Fine-Needle Aspiration Biopsy (FNAB). Scans described an early intense 99mTc-sestaMIBI uptake with no 99mTc-pertechnetate uptake in the left thyroid lobe larger nodule. Due to the suspicion of malignancy for this nodule, we performed an additional scan (1 hour before the classical 2 hours parathyroid delayed scan). The intense uptake persists in both delayed scans suggesting no malignant phenotype and which was confirmed after surgery by benign histology. In conclusion, using a 99mTc-sestaMIBI personalized protocol, related to the radiotracer cellular uptake mechanisms: 1 hour scan (supplementary image, corresponding to the maximum uptake pattern of 99mTc-sestaMIBI for cancer cells) and 2 hours scan (for parathyroid washout evaluation) may avoid unnecessary extensive thyroid surgery. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  99mTc-sestaMIBI; personalized protocol; thyroid/parathyroid nodules; uptake mechanisms

Year:  2021        PMID: 35342463      PMCID: PMC8919489          DOI: 10.4183/aeb.2021.393

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  22 in total

1.  SNM practice guideline for parathyroid scintigraphy 4.0.

Authors:  Bennett S Greenspan; Gary Dillehay; Charles Intenzo; William C Lavely; Michael O'Doherty; Christopher J Palestro; William Scheve; Michael G Stabin; Delynn Sylvestros; Mark Tulchinsky
Journal:  J Nucl Med Technol       Date:  2012-03-27

2.  Value of 99mTc-MIBI SPECT/CT parathyroid imaging and ultrasonography for concomitant thyroid carcinoma.

Authors:  Rui Guo; Jiqiu Wang; Min Zhang; Miao Zhang; Hongping Meng; Yifan Zhang; Biao Li
Journal:  Nucl Med Commun       Date:  2017-08       Impact factor: 1.690

3.  Feasibility and safety of minimally invasive radioguided parathyroidectomy using very low intraoperative dose of Tc-99m MIBI.

Authors:  Mostafa Mehrabibahar; Zohreh Mousavi; Ramin Sadeghi; Parvin Layegh; Masoumeh Nouri; Mehdi Asadi
Journal:  Int J Surg       Date:  2017-02-10       Impact factor: 6.071

4.  RADIOGUIDED MEDIASTINAL PARATHYROIDECTOMY IN A PATIENT WITH PERSISTENT RENAL HYPERPARATHYROIDISM.

Authors:  R Dănilă; R Livadariu; C Ştefănescu; D Ciobanu; L Ionescu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

5.  Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT.

Authors:  T H Vu; D Schellingerhout; N Guha-Thakurta; J Sun; W Wei; S C Kappadth; N Perrier; E E Kim; E Rohren; H H Chuang; F C Wong
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-06       Impact factor: 3.825

6.  Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.

Authors:  Albert Kao; Yu-Chien Shiau; Shih-Chuan Tsai; Jhi-Joung Wang; Shung-Tai Ho
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-04-27       Impact factor: 9.236

Review 7.  Parathyroid nuclear scan. A focused review on the technical and biological factors affecting its outcome.

Authors:  Subramanian Kannan; Mira Milas; Donald Neumann; Rikesh T Parikh; Alan Siperstein; Angelo Licata
Journal:  Clin Cases Miner Bone Metab       Date:  2014-01

Review 8.  Less is More: Comparing the 2015 and 2009 American Thyroid Association Guidelines for Thyroid Nodules and Cancer.

Authors:  Brian W Kim; Wina Yousman; Wei Xiang Wong; Cheng Cheng; Elizabeth A McAninch
Journal:  Thyroid       Date:  2016-05-19       Impact factor: 6.568

9.  MINIMALLY INVASIVE PARATHYROIDECTOMY FOR PRIMARY HYPERPARATHYROIDISM.

Authors:  M Urkan; Y S Peker; E Ozturk
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

10.  Incremental Value of Sestamibi SPECT/CT Over Dual-Phase Planar Scintigraphy in Patients With Primary Hyperparathyroidism and Inconclusive Ultrasound.

Authors:  Roberta Assante; Emilia Zampella; Emanuele Nicolai; Wanda Acampa; Emilia Vergara; Carmela Nappi; Valeria Gaudieri; Giovanni Fiumara; Michele Klain; Mario Petretta; Alberto Cuocolo
Journal:  Front Med (Lausanne)       Date:  2019-07-16
View more
  1 in total

Review 1.  Personalized Diagnosis in Differentiated Thyroid Cancers by Molecular and Functional Imaging Biomarkers: Present and Future.

Authors:  Laura Teodoriu; Letitia Leustean; Maria-Christina Ungureanu; Stefana Bilha; Irena Grierosu; Mioara Matei; Cristina Preda; Cipriana Stefanescu
Journal:  Diagnostics (Basel)       Date:  2022-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.